Praxisgemeinschaft Jerichow Schulze

Praxisgemeinschaft Jerichow Schulze is advancing research in cardiovascular diseases, targeting conditions such as hypertension, high cardiovascular risk, and established heart disease. The studies aim to test new therapies that may lower the incidence of heart attacks, strokes, and heart‑failure events while ensuring safety and tolerability.

• Risk reduction in cardiovascular mortality
• Management of hypertension
• Evaluation of novel peptide therapeutics

At this German research site, investigators are evaluating innovative approaches to protect heart health and improve long‑term outcomes for patients.

The centre also focuses on digestive system diseases, specifically irritable bowel syndrome and ulcerative colitis. Clinical trials assess the efficacy and safety of agents such as MYRRHINIL‑INTEST for IBS‑D/M and compare biologics like risankizumab with existing treatments to achieve symptom relief and sustained remission.

• Therapeutic options for IBS‑D and IBS‑M
• Biologic comparisons for ulcerative colitis
• Patient‑reported outcome improvements

Research at this site seeks to bring more effective, well‑tolerated treatments to individuals living with chronic gastrointestinal disorders.